How to Get Abecma (idecabtagene vicleucel) Approved by UnitedHealthcare in Michigan: Timeline, Appeals, and Forms
Answer Box: Getting Abecma Covered by UnitedHealthcare in Michigan
UnitedHealthcare requires prior authorization for Abecma (idecabtagene vicleucel) CAR-T therapy. The fastest path: Submit PA through the UHCprovider.com portal with complete documentation showing relapsed/refractory multiple myeloma after ≥2 prior lines (including IMiD, proteasome inhibitor, and anti-CD38 agent). If denied,